mortality/aging
• the mean age of survival of double heterozygotes is slightly reduced relative to mice heterozygous for Rb1tm1Tyj alone (9 months vs 11 months)
|
neoplasm
• in nearly all double heterozygotes with pituitary and thyroid tumors, the wild-type allele of Rb1 is lost whereas the wild-type allele of Trp53 is retained
|
• one of 7 individual double heterozygotes analyzed displayed a single pinealoblastoma (not detected in single heterozygotes); the wild-type alleles of both Rb1 and Trp53 were lost in this pineal tumor
|
• each of 67 double heterozygotes analyzed developed pituitary tumors of the intermediate lobe
|
• ~75% of double heterozygous mice develop medullary thyroid tumors
|
• 14% of a total of 14 individual double heterozygotes analyzed displayed islet cell carcinomas (not detected in single heterozygotes)
• notably, the wild-type alleles of both Rb1 and Trp53 were lost in tumors of the islet cells of the pancreas
|
• 6% of a total of 67 individual double heterozygotes analyzed displayed anaplastic sarcomas
• such tumors were shown to be more aggressive and arise at an earlier age than those occurring in single Trp53tm1Tyj heterozygotes
• notably, the wild-type alleles of both Rb1 and Trp53 were lost in these anaplastic sarcomas
|
• one of 7 individual double heterozygotes analyzed displayed a leiomyosarcoma
|
respiratory system
• 8% of a total of 12 individual double heterozygotes analyzed displayed bronchial hyperplasia
|
muscle
• one of 7 individual double heterozygotes analyzed displayed a leiomyosarcoma
|
endocrine/exocrine glands
• each of 67 double heterozygotes analyzed developed pituitary tumors of the intermediate lobe
|
• ~75% of double heterozygous mice develop medullary thyroid tumors
|
• 14% of a total of 14 individual double heterozygotes analyzed displayed islet cell carcinomas (not detected in single heterozygotes)
• notably, the wild-type alleles of both Rb1 and Trp53 were lost in tumors of the islet cells of the pancreas
|
nervous system
• each of 67 double heterozygotes analyzed developed pituitary tumors of the intermediate lobe
|